Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs

Bartenschlager, 2000, Replication of hepatitis C virus, J Gen Virol, 81, 1631, 10.1099/0022-1317-81-7-1631 World Health Organization, 2000, Hepatitis C: global prevalence (update), Wkly Epidemiol Rec, 75, 18 Hoofnagle, 1997, Hepatitis C: the clinical spectrum of disease, Hepatology, 26, 15S, 10.1002/hep.510260703 Theodore, 2000, Natural history and disease manifestations of hepatitis C infection, Curr Top Microbiol Immunol, 242, 44 Moradpour, 1999, Current and evolving therapies for hepatitis C, Eur J Gastroenterol Hepatol, 11, 1199, 10.1097/00042737-199911000-00002 Zeuzem, 2000, Peginterferon alpha-2α in patients with chronic hepatitis C, N Engl J Med, 343, 1666, 10.1056/NEJM200012073432301 Heathcote, 2000, Peginterferon alpha-2α in patients with chronic hepatitis C and cirrhosis, N Engl J Med, 343, 1673, 10.1056/NEJM200012073432302 Goodbourn, 2000, Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures, J Gen Virol, 81, 2341, 10.1099/0022-1317-81-10-2341 Boehm, 1997, Cellular responses to interferon-γ, Annu Rev Immunol, 15, 749, 10.1146/annurev.immunol.15.1.749 Cella, 1999, Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat Med, 5, 919, 10.1038/11360 Lohmann, 1999, Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line, Science, 285, 110, 10.1126/science.285.5424.110 Lohmann, 2001, Mutations in hepatitis C virus RNAs conferring cell culture adaptation, J Virol, 75, 1437, 10.1128/JVI.75.3.1437-1449.2001 Pietschmann, 2001, Characterization of cell lines carrying self-replicating hepatitis C virus RNAs, J Virol, 75, 1252, 10.1128/JVI.75.3.1252-1264.2001 Frese, 2001, Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway, J Gen Virol, 82, 723, 10.1099/0022-1317-82-4-723 Blight, 2000, Efficient initiation of HCV RNA replication in cell culture, Science, 290, 1972, 10.1126/science.290.5498.1972 Guo, 2001, Effect of alpha interferon on the hepatitis C virus replicon, J Virol, 75, 8516, 10.1128/JVI.75.18.8516-8523.2001 Nakabayashi, 1982, Growth of human hepatoma cells lines with differentiated functions in chemically defined medium, Cancer Res, 42, 3858 Krieger, 2001, Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations, J Virol, 75, 4614, 10.1128/JVI.75.10.4614-4624.2001 Moradpour, 1996, Characterization of three novel monoclonal antibodies against hepatitis C virus core protein, J Med Virol, 48, 234, 10.1002/(SICI)1096-9071(199603)48:3<234::AID-JMV4>3.0.CO;2-9 Wölk, 2000, Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines, J Virol, 74, 2293, 10.1128/JVI.74.5.2293-2304.2000 Moradpour, 2002, Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase, J Biol Chem, 277, 593, 10.1074/jbc.M108748200 Vraetz, 1999, Regulation of β2-microglobulin expression in different human cell lines by proinflammatory cytokines, Nephrol Dial Transplant, 14, 2137, 10.1093/ndt/14.9.2137 Melén, 2000, Interferon-induced gene expression and signalling in human hepatoma cell lines, J Hepatol, 33, 764, 10.1016/S0168-8278(00)80308-6 Karupiah, 2000, NADPH oxidase, Nramp1 and nitric oxide in the host microbiol response, Rev Immunogenetics, 2, 387 Marletta, 1988, Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate, Biochemistry, 27, 8706, 10.1021/bi00424a003 Moore, 1994, L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase, J Med Chem, 37, 3886, 10.1021/jm00049a007 Shami, 1998, Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide, Leukemia, 12, 1461, 10.1038/sj.leu.2401131 Boucher, 1994, N omega-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase, Biochem Biophys Res Commun, 203, 1614, 10.1006/bbrc.1994.2371 Daghigh, 1994, Inhibition of rat liver arginase by an intermediate in NO synthesis, NG-hydroxy-L-arginase: implications for the regulation of nitric oxide biosynthesis by arginase, Biochem Biophys Res Commun, 202, 174, 10.1006/bbrc.1994.1909 Bodaghi, 1999, Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells, J Immunol, 162, 957, 10.4049/jimmunol.162.2.957 Cady, 1991, 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)-thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase, Arch Biochem Biophys, 291, 326, 10.1016/0003-9861(91)90142-6 Guidotti, 2001, Noncytolytic control of viral infections by the innate and adaptive immune response, Annu Rev Immunol, 19, 65, 10.1146/annurev.immunol.19.1.65 Guidotti, 1999, Viral clearance without destruction of infected cells during acute HBV infection, Science, 284, 825, 10.1126/science.284.5415.825 Guidotti, 2000, Cytokine-mediated control of viral infections, Virology, 273, 221, 10.1006/viro.2000.0442 Cooper, 1999, Analysis of a successful immune response against hepatitis C virus, Immunity, 10, 439, 10.1016/S1074-7613(00)80044-8 Chang, 2001, Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection, Hepatology, 33, 267, 10.1053/jhep.2001.21162 Lechner, 2000, Analysis of successful immune responses in persons infected with hepatitis C virus, J Exp Med, 191, 1499, 10.1084/jem.191.9.1499 Gerlach, 1999, Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C, Gastroenterology, 117, 933, 10.1016/S0016-5085(99)70353-7 Thimme R Bukh J Pemberton J Purcell RH Chisari FV T cell responses and intrahepatic cytokine profiles in HBV and HCV-infected chimpanzees Tambur, 2001, Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients, Transplantation, 10, 1475, 10.1097/00007890-200105270-00020 Sarih, 2000, Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection, Immunol Lett, 74, 117, 10.1016/S0165-2478(00)00210-8 Makris, 1996, The natural history of chronic hepatitis C in haemophiliacs, Br J Haematol, 94, 746, 10.1046/j.1365-2141.1996.02343.x Cribier, 1995, High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV, AIDS, 9, 1131, 10.1097/00002030-199510000-00003 Eyster, 1994, Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study, Blood, 84, 1020, 10.1182/blood.V84.4.1020.1020 Mikovits, 1998, Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production, Mol Cell Biol, 18, 5166, 10.1128/MCB.18.9.5166 Barcova, 1998, gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production, J Infect Dis, 177, 905, 10.1086/515230 Battegay, 2000, Human immunode-ficiency and hepatitis C virus coinfection influenced by interferon-gamma, Immunol Lett, 71, 141 Haller, 1998, Mx proteins: mediators of innate resistance to RNA viruses, Rev Sci Tech, 17, 220, 10.20506/rst.17.1.1084 Clemens, 1997, The double-stranded RNA-dependent protein kinase PKR: structure and function, J Interferon Cytokine Res, 17, 503, 10.1089/jir.1997.17.503 Tan, 2001, How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A, Virology, 284, 1, 10.1006/viro.2001.0885 Taylor, 1999, Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein, Science, 285, 107, 10.1126/science.285.5424.107 Saura, 1999, An antiviral mechanism of nitric oxide: inhibition of a viral protease, Immunity, 10, 21, 10.1016/S1074-7613(00)80003-5 Guidotti, 2000, Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice, J Exp Med, 191, 1247, 10.1084/jem.191.7.1247 Akaike, 1996, Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals, Proc Natl Acad Sci U S A, 93, 2448, 10.1073/pnas.93.6.2448 Karupiah, 1998, Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice, J Exp Med, 188, 1541, 10.1084/jem.188.8.1541 Mihm, 1997, Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury, Hepatology, 26, 451, 10.1002/hep.510260228 Majano, 1998, Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation, J Clin Invest, 101, 1343, 10.1172/JCI774 Schweyer, 2000, Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection, Gut, 46, 255, 10.1136/gut.46.2.255 Carlin, 1989, Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects, EXS, 45, 535